Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates

Pacira BioSciences (PCRX) reported first-quarter 2025 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate of 57 cents. The company had also reported adjusted earnings of 62 cents per share in the year-ago quarter.Total revenues amounted to $168.9 million, which increased 1% year over year. The reported figure, however, missed the Zacks Consensus Estimateof$ 175million. (See the Zacks Earnings Calendar to stay ahead of market-making news.)PCRX’s Q1 Results in DetailPacira BioScie ...